Chapter 3 Laboratory Diagnosis of Rubella and Congenital Rubella

Perspectives in Medical Virology

Volumn 15, Issue , 2006, Pages 39-77

  Best, Jennifer M ^a   Enders, Gisela ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b Infectiology and Epidemiology eV and Labor Prof Dr med Gisela Enders and Partner   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751188724     PISSN: 01687069     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0168-7069(06)15003-X     Document Type: Review

References (127)

1. Akingbade D., Cohen B.J., and Brown D.W.G. Detection of low-avidity immunoglobulin G in oral fluid samples: new approach for rubella diagnosis and surveillance. Clin Diagn Lab Immunol 10 (2003) 189-190
2. Andrews N., Pebody R.G., Berbers G., et al. The European sero-epidemiology network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 125 1 (2000) 127-141
3. Banatvala J.E., and Brown D.W.G. Rubella. Lancet 363 (2004) 1127-1137
4. Ben Saleh A., Zaatour A., and Pomery L. Validation of a modified commercial assay for the detection of rubella-specific IgG in oral fluid for use in population studies. J Virol Methods 114 (2003) 151-158
5. Best J.M., and Banatvala J.E. A comparison of RK13, vervet monkey kidney and patas monkey kidney cell cultures for the isolation of rubella virus. J Hyg (Camb) 65 (1967) 263-271
6. Best J.M., and Banatvala J.E. Serum IgM and IgG responses in postnatally acquired rubella. Lancet 1 (1969) 65-68
7. Best J.M., Banatvala J.E., Morgan-Capner P., and Miller E. Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. Br Med J 299 (1989) 773-775
8. Best JM, Castillo-Solorzano C, Spika JS, et al. Reducing the global burden of congenital rubella syndrome. Report of the WHO Steering Committee on Research Related to Measles and Rubella Vaccines and Vaccination, June 2004. J Infect Dis 2005; 192(11): 1890.
9. Best JM, O'Shea S. Rubella virus. In: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections (Lennette EH, Lennette DA, Lennette ET, editors). 7th ed. Washington, DC: American Public Health Association 1995; pp. 583-600.
10. Best J.M., O'Shea S., Tipples G., et al. Interpretation of rubella serology in pregnancy-pitfalls and problems. Br Med J 325 (2002) 47-48
11. Bosma T.J., Best J.M., Corbett K.M., et al. Nucleotide sequence analysis of a major antigenic domain of 22 rubella virus isolates. J Gen Virol 77 (1996) 2523-2530
12. Bosma T.J., Corbett K.M., Eckstein M.B., et al. Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol 33 (1995) 2881-2887
13. Bosma T.J., Corbett K.M., O'Shea S., et al. PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol 33 (1995) 1075-1079
14. Böttiger B., and Jensen I.P. Maturation of rubella IgG avidity over time after acute rubella infection. Clin Diagn Virol 8 2 (1997) 105-111
15. Bullens D., Smets K., and Vanhaesebrouck P. Congenital rubella syndrome after maternal reinfection. Clin Pediatr (Phila) 39 2 (2000) 113-116
16. Chantler S., Evans C.J., Mortimer P.P., Cradock-Watson J.E., Ridehalgh M.K.S., Cooper L.Z., Florman A.L., Ziring P.R., and Krugman S. A comparison of antibody capture radio- and enzyme immunoassays with immunofluorescence for detecting IgM antibody in infants with congenital rubella. J Virol Methods 4 (1982) 305-313
17. Cooper L.Z. Congenital rubella in the United States. In: Krugman S., and Gerhson A. (Eds). Progress in Clinical and Biological Research 3 (1975), Alan R Liss, Inc, New York 1-21
18. Cooper L.Z., Forman A.L., et al. Loss of rubella hemagglutination inhibition antibody in congenital rubella. Failure of seronegative children with congenital rubella to respond to HPV-77 rubella vaccine. Am J Dis Child 122 (1971) 397-403
19. Cooper L.Z., and Krugman S. Clinical manifestations of postnatal and congenital rubella. Arch Ophthalmol 77 (1967) 434
20. Cooray S., Warrener L., and Jin L. Improved RT-PCR for diagnosis and epidemiological surveillance of rubella. J Clin Virol 35 (2006) 73-80
21. Corcoran C., and Hardie D.R. Serologic diagnosis of congenital rubella: a cautionary tale. Pediatr Infect Dis J 24 3 (2005) 286-287
22. Cordoba P., Lanoel A., Grutadauria S., and Zapata M. Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status. Clin Diagn Lab Immunol 7 6 (2000) 964-966
23. Crino J.P. Ultrasound and fetal diagnosis of perinatal infection. Clin Obstet Gynecol 42 (1999) 71-80
24. Cutts F., and Brown D.W.G. The contribution of field tests to measles surveillance and control: a review of available methods. Rev Med Virol 5 (1995) 35-40
25. de Oliveira S.A., Siqueira M.M., and Brown D.W.G. Diagnosis of rubella infection by detecting specific immunoglobulin M antibodies in saliva samples: a clinic-based study in Niteroi RJ, Brazil. Rev Soc Bras Med Trop 33 (2000) 335-339
26. De Swart R.L., Nur Y., and Abdallah A. Combination of reverse transcriptase PCR analysis and immunoglobulin M detection on filter paper blood samples allows diagnostic and epidemiological studies of measles. J Clin Microbiol 39 1 (2001) 270-273
27. del Mar Mosquera M., de Ory F., Moreno M., and Echevarria J.E. Simultaneous detection of measles virus, rubella virus, and parvovirus B19 by using multiplex PCR. J Clin Microbiol 40 (2002) 111-116
28. Department of Health Screening for Infectious Diseases in Pregnancy. Standards to Support the UK Antenatal Screening Programme. London: Stationery Office; 2003. Available from http://www.dh.gov.uk/assetRoot/04/09/20/49/04092049.pdf.
29. Eckstein M.B., Brown D.W.G., Foster A., et al. Congenital rubella in south India: diagnosis using saliva from infants with cataract. Br Med J 312 (1996) 161
30. Eggers M., Enders M., Strobel S., et al. A novel and rapid method for determination of rubella virus immunoglobulin G avidity. Clin Microbiol Infect 11 Suppl 2 (2005) 33
31. Enders G. Problems of rubella diagnosis by various IgM techniques and the need for test combinations. In: Habermehl K.O. (Ed). Rapid Methods and Automation in Microbiology and Immunology (1985), Springer, Berlin 146-160
32. Enders G. Vergleich eines einfachen Latex-Agglutinationstestes mit dem Röteln-Häagglutinationshemmtest und Hämolysis-in-Gel-Test. Lab Med 11 (1987) 221-223
33. Enders G. Diagnostik von Rötelninfektionen in der Schwangerschaft durch konventionelle, immunologische und molekular-biologische Methoden. In: Deinhardt F., Maass G., and Spiess H. (Eds). Neues in der Virusdiagnostik (1991), Richard-Haas-Symposium der DVV 133-152
34. Enders G. Qualitätssicherung in der Serodiagnostik bei der Mutterschaftsvorsorge: Qualitätssicherung und aktuelle Aspekte zur Serodiagnostik der Röteln in der Schwangerschaft. Symposium Moderne Aspekte der Mikrobiologischen Diagnostik, Kurzfassungen von Vorträgen des 3. Symposium am 04. Dezember 1996 in Berlin. Clin Lab 43 (1997) 1019-1032
35. Enders, G. Mütterliche Infektionen mit dem Risiko der prä- und perinatalen Übertragung-Teil I. Labormedizinische Aspekte wichtiger Infektionen im Überblick. Gynäkologie+Geburtshilfe 06, 2005; 6: 38-46.
36. Enders G., Bäder U., Lindemann L., et al. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 5 (2001) 362-377
37. Enders G., and Jonatha W. Prenatal diagnosis of intrauterine rubella. Infection 15 (1987) 162-164
38. Enders G., and Knotek F. Detection of IgM antibodies against rubella virus: comparison of two indirect ELISAs and an anti-IgM capture immunoassay. J Med Virol 19 (1986) 377-386
39. Enders G., and Knotek F. Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection. Infection 17 4 (1989) 218-226
40. Enders G., Knotek F., and Pacher U. Comparison of various serological methods and diagnostic kits for the detection of acute, recent, and previous rubella infection, vaccination, and congenital infections. J Med Virol 16 (1985) 219-232
41. Forrest J.M., Turnbull F.M., Sholler G.F., et al. Gregg's congenital rubella patients 60 years later. Med J Aust 177 (2002) 664-667
42. Frey T.K., Abernathy E.S., Bosma T.J., et al. Molecular analysis of rubella virus epidemiology across three continents, North America, Europe and Asia, 1961-1997. J Infect Dis 178 (1998) 642-650
43. Gerna G., Zannino M., Revello M., et al. Development and evaluation of a capture enzyme-linked immunosorbent assay for determination of rubella immunoglobulin M using monoclonal antibodies. J Clin Microbiol 25 (1987) 1033-1038
44. Gießauf A., Letschka T., Walder G., et al. A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity. J Immunol Methods 287 (2004) 1-11
45. 5- und RA 27/3-Impfstoffen von 11-16 Jahre alten Mädchen: Untersuchungen zur Antikörperentwicklung und Antikörperpersistenz nach 4 und 8 Jahren. Immun Infekt 11 (1983) 79-90
46. Grangeot-Keros L., and Enders G. Evaluation of a new enzyme immunoassay based on recombinant rubella virus-like particles for detection of immunoglobulin M antibodies to rubella virus. J Clin Microbiol 35 2 (1997) 398-401
47. Grangeot-Keros L., Pustowoit B., and Hobman T. Evaluation of Cobas Core Rubella IgG EIA recomb, a new enzyme immunoassay based on recombinant rubella-like particles. J Clin Microbiol 33 (1995) 2392-2394
48. Gunter EW, Lewis BG, Koncikowski SM. Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994, U.S. department of health and human services (http://www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/labman.pdf); 1996.
49. Halonen P.E., Ryan I.H., and Stewart J.A. Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells. Proc Soc Exp Biol Med 125 (1967) 162-167
50. Harcourt G., Best J.M., and Banatvala J.E. Rubella specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine induced immunity following intranasal challenge. J Infect Dis 142 (1980) 145-155
51. Hedman K., and Rousseau S.A. Measurement of avidity of specific IgG for verification of recent primary rubella. J Med Virol 27 (1989) 288-292
52. Hedman K., and Seppälä I. Recent rubella virus infection indicated by a low avidity of specific IgG. J Clin Immunol 8 (1988) 214-221
53. Helfand R.F., Keyserling H.L., Williams I., Murray A., Mei J., Moscatiello C., Icenogle J., and Bellini W.J. Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples. J Med Virol 65 4 (2001) 751-757
54. Henquell C., Bournazeau J.A., Vanlieferinghen P., et al. Recrudescence en 1997 des infections rubéoliques pendant la grossesse. La Presse Méd 28 15 (1999) 777-780
55. Hobman T.C., Lundstrom M.L., Mauracher C.A., et al. Assembly of rubella virus structural proteins into virus-like particles in transfected cells. Virology 202 2 (1994) 574-585
56. Hodgson J., and Morgan-Capner P. Evaluation of a commercial antibody capture enzyme immunoassay for the detection of rubella specific IgM. J Clin Pathol 37 (1984) 573-577
57. Hudson P., and Morgan-Capner P. Evaluation of 15 commercial enzyme immunoassays for the detection of rubella-specific IgM. Clin Diagn Virol 5 (1996) 21-26
58. Jacquemard F., Hohlfeld P., Mirlesse V., et al. Prenatal diagnosis of fetal infections. In: Remington J.S., and Klein J.O. (Eds). Infectious Diseases of the Fetus and Newborn Infant (1995), WB Saunders Company, Philadelphia 99-107
59. Jauniaux E., and Rodeck C. Use, risks and complications of amniocentesis and chorionic villous sampling for prenatal diagnosis in early pregnancy. Early Pregnancy 1 4 (1995) 245-252
60. Jin L., Vyse A., and Brown D.W. The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella. Bull World Health Organ 80 (2002) 76-77
61. Karapanagiotidis T., Riddell M., and Kelly H. Detection of rubella immunoglobulin M from dried venous blood spots using a commercial enzyme immunoassay. Diagn Microbiol Infect Dis 53 (2005) 107-111
62. Katow S. Rubella virus genome diagnosis during pregnancy and mechanism of congenital rubella. Intervirology 41 (1998) 163-169
63. Kurtz J.B., Mortimer P.P., Mortimer P.R., et al. Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories. J Hyg (Camb) 84 2 (1980) 213-222
64. Macé M., Cointe D., Six C., et al. Diagnostic value of reverse transcription-PCR of amniotic fluid for prenatal diagnosis of congenital rubella infection in pregnant women with confirmed primary rubella infection. J Clin Microbiol 42 10 (2004) 4818-4820
65. Matter L., Gorgievski-Hrisoho M., and Germann D. Comparison of four enzyme immunoassays for detection of immunoglobulin M antibodies against rubella virus. J Clin Microbiol 32 (1994) 2134-2139
66. Matter L., Kogelschatz K., and Germann D. Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations. J Infect Dis 175 4 (1997) 749-755
67. McCarthy K., Taylor-Robinson C.H., and Pillinger S.E. Isolation of rubella virus from cases in Britain. Lancet II (1963) 593
68. McKie A., Vyse A., and Maple C. Novel methods for the detection of microbial antibodies in oral fluid. Lancet Inf Dis 2 (2002) 18-24
69. Meitsch K., Enders G., Wolinsky J.S., et al. The role of rubella-immunoblot and rubella-peptide-EIA for the diagnosis of the congenital rubella syndrome during the prenatal and newborn periods. J Med Virol 51 4 (1997) 280-283
70. Meurman O.H., Viljanen M.K., and Granfors K. Solid-phase radioimmunoassay of rubella virus immunoglobulin M antibodies: comparison with sucrose density gradient centrifugation test. J Clin Microbiol 5 (1977) 257-262
71. Miller E., Cradock-Watson J.E., and Pollock T.M. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 2 8302 (1982) 781-784
72. Miller E., Tookey P., et al. Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep 4 (1994) R146-R152
73. Morgan-Capner P, Crowcroft NS. PHLS Joint Working Party of the Advisory Committees of Virology and Vaccines and Immunisation, Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy). Commun Dis Public Health 2002; 5(1): 59-71. [http://www.hpa.org.uk/cdph/issues/CDPHvol5/No1/rash illness guidelines.pdf].
74. Morgan-Capner P., Miller E., Vurdien J.E., and Ramsay M.E. Outcome of pregnancy after maternal reinfection with rubella. Commun Dis Rep 1 6 (1991) R57-R59
75. Morris M., Cohen B., Andrews N., and Brown D. Stability of total and rubella-specific IgG in oral fluid samples: the effect of time and temperature. J Immunol Methods 266 (2002) 111-116
76. Mortimer P.P., and Parry J.V. Non-invasive virological diagnosis: are saliva and urine specimens adequate substitutes for blood?. Rev Med Virol 1 (1991) 73-78
77. Nedeljkovic J., Jovanovic T., Mladjenovic S., et al. Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells. J Clin Virol 14 2 (1999) 119-131
78. Nokes D.J., Nigatu W., Abebe A., et al. A comparison of oral fluid and serum for the detection of rubella-specific antibodies in a community study in Addis Ababa, Ethiopia. Trop Med Internat Health 3 (1998) 258-267
79. O'Shea S., Best J.M., and Banatvala J.E. Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis 148 (1983) 639-647
80. O'Shea S., Best J.M., and Banatvala J.E. A lymphocyte transformation assay for the diagnosis of congenital rubella. J Virol Methods 37 (1992) 139-148
81. O'Shea S., Corbett K.M., Barrow S.M., et al. Rubella reinfection; role of neutralising antibodies and cell-mediated immunity. Clin Diagn Virol 2 (1994) 349-358
82. O'Shea S., Dunn H., Palmer S., et al. Automated rubella antibody screening: a cautionary tale. J Med Microbiol 48 (1999) 1047
83. Parker S.P., and Cubitt W.D. The use of the dried blood spot sample in epidemiological studies. J Clin Pathol 52 (1999) 633-639
84. Parkman P.D., Buescher E.L., and Artenstein M.S. Recovery of the rubella virus from recruits. Proc Soc Exp Biol Med 111 (1962) 225-230
85. Parkman P.D., Mundon F.K., McCown J.M., and Buescher E.L. Studies of rubella. II. Neutralization of the virus. J Immunol 93 (1964) 608-617
86. Perry K.R., Brown W.G., et al. Detection of measles, mumps and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol 40 (1993) 235-240
87. Pitcovski J., Shmueli E., Krispel S., and Levi N. Storage of viruses on filter paper for genetic analysis. J Virol Methods 83 (1999) 21-26
88. Pustowoit B., Grangeot-Keros L., Hobman T.C., and Hofmann J. Evaluation of recombinant rubella-like particles in a commercial immunoassay for the detection of anti-rubella IgG. Clin Diagn Virol 5 (1996) 13-20
89. Pustowoit B., and Liebert U.G. Predictive value of serological tests in rubella virus infection during pregnancy. Intervirology 41 4, 5 (1998) 170-177
90. Ramsay M., Reacher M., O'Flynn C., et al. Causes of morbilliform rash in a highly immunised English population. Arch Dis Child 87 (2002) 202-206
91. Ramsay M.E., Brugha R., Brown D.W.G., et al. Salivary diagnosis of rubella: a study of notified cases in the United Kingdom, 1991-4. Epidemiol Infect 120 (1998) 315-319
92. Reef S.E., Plotkin S., Cordero J.F., et al. Preparing for elimination of congenital rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin Infect Dis 31 (2000) 85-95
93. Revello M.G., Baldanti F., Sarasini A., et al. Prenatal diagnosis of rubella virus infection by direct detection and semiquantitation of viral RNA in clinical samples by reverse transcription-PCR. J Clin Microbiol 35 (1997) 708-713
94. Robert-Koch-Institut. Bekämpfung der Masern und Konnatalen Röteln: WHO-Strategie in der europäischen Region und aktueller Stand in Deutschland. Epidem Bull 10 (2004) 79-84
95. Robertson S.E., Featherstone D.A., Gacic-Dobo M., and Hersh B.S. Rubella and congenital rubella syndrome: global update. Pan Am J Public Health 14 5 (2003) 306-315
96. Schmidt M., Lidqvist C., Salmi A., and Oker-Blom C. Detection of rubella virus-specific immunoglobulin M antibodies with a baculovirus-expressed E1 protein. Clin Diagn Lab Immunol 3 2 (1996) 216-218
97. Skendzel L.P. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 106 2 (1996) 170-174
98. Starkey W.G., Newcombe J., Corbett K.M., et al. Use of rubella E1 fusion proteins for the detection of rubella antibodies. J Clin Microbiol 33 (1995) 270-274
99. Stewart G.L., Parkman P.D., Hopps H.E., et al. Rubella-virus hemagglutination-inhibition test. N Engl J Med 276 (1967) 554-557
100. Tanemura M., Suzumori K., Yagami Y., and Katow S. Diagnosis of fetal rubella infection with reverse transcription and nested polymerase chain reaction: a study of 34 cases diagnosed in fetus. Am J Obstet Gynecol 174 (1996) 578-582
101. Tang J.W., Aarons E., Hesketh L.M., et al. Prenatal diagnosis of congenital rubella infection in the second trimester of pregnancy. Prenat Diagn 23 (2003) 509-512
102. Tedder R.S., Yao J.L., and Anderson M.J. The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgM. J Hyg (Camb) 88 2 (1982) 335-350
103. Thomas H.I.J., and Morgan-Capner P. Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect 101 (1988) 591-598
104. Thomas H.I.J., and Morgan-Capner P. Rubella-specific IgG1 avidity: a comparison of methods. J Virol Methods 31 (1991) 219-228
105. Thomas H.I.J., Morgan-Capner P., Cradock-Watson J.E., et al. Slow maturation of IgG1, avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology. J Med Virol 41 (1993) 196-200
106. Thomas H.I.J., Morgan-Capner P., Enders G., et al. Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods 39 (1992) 149-155
107. Thomas H.I.J., Morgan-Capner P., Roberts A., and Hesketh L. Persistent rubella-specific IgM reactivity in the absence of recent primary rubella and rubella reinfection. J Med Virol 36 (1992) 188-192
108. Tipples G.A., Hamkar R., Mohktari-Azad T., et al. Evaluation of rubella IgM enzyme immunoassays. J Clin Virol 30 (2004) 233-238
109. Tischer A., and Gerike E. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Vaccine 18 (2000) 1382-1392
110. Tookey P.A., Cortina-Borja M., and Peckham C.S. Rubella susceptibility among pregnant women in North London. J Public Health Med 24 3 (2002) 211-216
111. Tookey P. Rubella in England, Scotland and Wales. Eurosurveillance Monthly 9 4 (2004) 21-22
112. Tzeng W.P., Zhou Y., Icenogle J., and Frey T.K. Novel replicon-based reporter gene assay for detection of rubella virus in clinical specimens. J Clin Microbiol 43 2 (2005) 879-885
113. Ueda K., Tokugawa K., Fukushige J., et al. Hemaglutination inhibition antibodies in congenital rubella syndrome. Am J Dis Child 141 (1987) 211-212
114. Vaananen P., Haiva V.M., Koskela P., and Meurman O. Comparison of a simple latex agglutination test with hemolysis in-gel, hemagglutination inhibition, and radioimmunoassay for detection of rubella virus antibodies. J Clin Microbiol 21 5 (1985) 793-795
115. Vejtorp M., Fanoe E., and Leerhoy J. Diagnosis of postnatal rubella by the enzyme-linked immunosorbent assay for rubella IgM and IgG antibodies. Acta Pathol Microbiol 87 (1979) 155-160
116. Vesikari T., and Vaheri A. Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies. Br Med J 1 (1968) 221
117. Vyse A.J., Brown D.W.G., Cohen B.J., et al. Detection of rubella virus-specific immunoglobulin G in saliva by an amplification-based enzyme-linked immunosorbent assay using monoclonal antibody to fluorescein isothiocyanate. J Clin Microbiol 37 (1999) 391-395
118. Vyse A.J., Cohen B.J., and Ramsay M.E. A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health 115 (2001) 201-207
119. Vyse A.J., and Jin L. An RT-PCR assay using oral fluid samples to detect rubella virus genome for epidemiological surveillance. Mol Cell Probes 16 (2002) 93-97
120. Weller T.H., and Neva F.A. Propagation in tissue culture of cytopathic agents form patients with rubella-like illness. Proc Soc Exp Biol Med 111 (1962) 215-225
121. Wolinsky J.S., Sukholutsky E., Moore W.T., et al. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain. J Virol 67 2 (1993) 961-968
122. World Health Organisation. Guidelines for Surveillance of Congenital Rubella Syndrome and Rubella. Field test version. WHO/V&B/99.22. Geneva: WHO; 1999.
123. World Health Organisation. Preventing congenital rubella syndrome. Wkly Epidemiol Rec 75 (2000) 290-295
124. World Health Organisation. Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses. Wkly Epidemiol Rec 80 (2005) 125-132
125. Zhang T., Mauracher C.A., Mitchell L.A., and Tingle A.J. Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays. J Clin Microbiol 30 4 (1992) 824-830
126. Zheng D.P., Frey T.K., Icenogle J., et al. Global distribution of rubella virus genotypes. Emerg Infect Dis 9 12 (2003) 1523-1530
127. Zrein M., Joncas J.H., Pedneault L., et al. Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination. J Clin Microbiol 31 6 (1993) 1521-1524